에 대한 최신 뉴스 Sasol (NYSE:SSL) 주식

Sasol

Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main segments: Energy business and Chemical business. It generates maximum revenue from the Chemicals segment. The company operates coal mines and its upstream interests in oil and gas, both of which are used as feedstock in the company's energy and chemicals operations. Geographically the company generates the majority of its revenue from South Africa.

News

Movers

AMKR

BILI

BRFS

IBRX

IRTC

ITCI

OLLI

RKLB

TALO

이들 중형주들은 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 빌리빌리(NASDAQ:BILI)의 주가는 지난주 &#39;산구오: 무딩티엔샤(San Guo: Mou Ding Tian Xia)&#39; 발표 이후 23.32% 상승했다. 또한 JP모건 애널리스트 다니엘 첸(Daniel Chen)은 중국의 빌리빌리를 중립에서 비중확대로 상향 조정하고 21달러 가격 목표를 발표했다. 

빌리빌리와 올리즈 바겐은 지난주 최대 성과를 보인 10개 중형주 중 일부 (6월 16일-6월 22일)

Sasol Ltd

SIMPLY SOLVENTLESS CNCTRT by SIMPLY SOLVENTLESS CONCENTRATES LTD.

Simply Solventless Concentrates Ltd

SINO SPLENDID HLDG by Sino Splendid Holdings Ltd

Sino Splendid Holdings Ltd

Siltronic AG

SOSILA LOGISTICS REIT INC by SOSILA LOGISTICS REIT INC.

SOSiLA Logistics REIT Inc

Syntax ETF Trust Stratified SmallCap ETF

SOCIETA SPORTIVA LAZIO by Societa Sportiva Lazio Spa

Societa Sportiva Lazio SpA

Santos Ltd

U.S. stock futures were mixed this morning, with the S&amp;P 500 futures gaining around 0.1% on Tuesday.
Shares of Vipshop Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIPS#NYSE">VIPS</a>) fell sharply in today's pre-market trading after reporting <a href="https://www.benzinga.com/news/earnings/24/08/40457669/chinese-discount-retailer-vipshop-posts-4-topline-decline-as-economy-hurts-sweetens-deal-with-1b-bu">second-quarter results.</a>
Vipshop reported second-quarter sales of $3.7 billion, down by 3.6% year-on-year, which topped the Wall Street view of $3.66 billion. Vipshop Holdings registered adjusted earnings per ADS of 54 cents, which aligns with the analyst consensus.
For the third quarter of 2024, the company expects its total net revenues to be between RMB20.5 billion-RMB21.6 billion, representing a year-over-year decrease of approximately 10%-5% versus consensus of RMB22.9 billion.
Vipshop shares dipped 7.2% to $13.00 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Jiayin Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFIN#NASDAQ">JFIN</a>) shares declined 6.9% to $5.65 in pre-market trading.</li>
<li>ATRenew Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) shares fell 6.7% to $2.65 in pre-market trading following second-quarter results.</li>
<li>Sasol Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>) shares fell 4.8% to $7.20 in pre-market trading after the company reported financial results for the year ended 30 June, 2024.</li>
<li>ExlService Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXLS#NASDAQ">EXLS</a>) shares fell 4% to $34.04 in pre-market trading.</li>
<li>Hesai Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>) shares slipped 3.8% to $4.36 in pre-market trading following second-quarter results.</li>
<li>Alvotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVO#NASDAQ">ALVO</a>) shares declined 3.4% to $12.55 in pre-market trading. Alvotech, last week, reported a year-over-year increase in H1 financial results.</li>
<li>Rezolve AI Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLV#NASDAQ">RZLV</a>) declined 2.4% to $8.00 in pre-market trading after dipping over 18% on Monday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/08/40454461/s-p-500-nasdaq-extend-gains-for-8th-consecutive-session-investor-sentiment-improves-but-greed-index">S&amp;P 500, Nasdaq Extend Gains For 8th Consecutive Session: Investor Sentiment Improves, But Greed Index Remains In &#8216;Fear&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

Markets

Trading Ideas

ALVO

EXLS

HSAI

JFIN

RERE

RZLV

VIPS

Vipshop, Hesai Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Key metrics</td>
<td colspan="1" rowspan="1">2024</td>
<td colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">Change %</td>
</tr>
<tr>
<td colspan="1" rowspan="1">(LBIT)/EBIT (R million)</td>
<td colspan="1" rowspan="1">(27 305)</td>
<td colspan="1" rowspan="1">21 520</td>
<td colspan="1" rowspan="1">&gt; (100)%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Headline earnings (R million)</td>
<td colspan="1" rowspan="1">11 513</td>
<td colspan="1" rowspan="1">33 777</td>
<td colspan="1" rowspan="1">(66)&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Basic (loss)/earnings per share (Rand)</td>
<td colspan="1" rowspan="1">(69,94)</td>
<td colspan="1" rowspan="1">14,00</td>
<td colspan="1" rowspan="1">&gt; (100)%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Headline earnings per share (Rand)</td>
<td colspan="1" rowspan="1">18,19</td>
<td colspan="1" rowspan="1">53,75</td>
<td colspan="1" rowspan="1">(66)&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Interim dividend (Rand per share)</td>
<td colspan="1" rowspan="1">2,00</td>
<td colspan="1" rowspan="1">7,00</td>
<td colspan="1" rowspan="1">(71)&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Final dividend (Rand per share)</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">10,00</td>
<td colspan="1" rowspan="1">&gt; (100)%</td>
</tr>
</tbody>
</table>
</figure>

Earnings

Sasol Ltd Reported 2024 EBIT Decline Of Over 100% YoY, EPS Decline Of 66% YoY

&nbsp;Shareholders and&nbsp;noteholders are referred to the SENS announcement of&nbsp;2 May 2024, where Sasol advised that Mr&nbsp;Hanr&eacute; Rossouw will step down as Chief Financial Officer and executive director of Sasol Limited on&nbsp;31 October 2024&nbsp;to pursue a career opportunity.&nbsp;

Sasol Names Walt Bruns As CFO, Effective September 1, Following Hanré Rossouw's Departure

Sasol Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>) shares are trading lower after it reported its <a target="_blank" href="https://www.benzinga.com/pressreleases/24/08/n40305881/sasol-limited-trading-statement-for-the-financial-year-ended-30-june-2024-and-retirement-of-non-ex" rel="noreferrer noopener">trading statement for FY24</a>.
The company expects an adjusted EBITDA decline of 2% to 17%, falling from R66.3 billion in the previous year to between R54.7 billion and R64.7 billion.
Sasol&#8217;s financial results were hurt by challenging market conditions, including low chemicals prices and tight margins.
However, these effects were partially mitigated by a stronger rand, higher oil prices, improved refining margins, and increased sales volumes. Stronger operational performance in the fourth quarter&nbsp;also boosted results in the latter half of the year.
For the year, earnings fell by over 100%, largely due to non-cash adjustments, including a net loss of R55.8 billion after tax (R75.4 billion gross) from impairments.
This included R45.5 billion (net of tax) for the Chemicals America Ethane value chain, R3.9 billion (net of tax) for Chemicals Africa&#8217;s Polyethylene, Chlor-Alkali, Polyvinyl Chloride, and Wax value chains, and R5.7 billion (net of tax) for the Secunda liquid fuels refinery, all driven by weaker market conditions and lower pricing.
The results also reflect an R15.3 billion derecognition of deferred tax assets from unutilized losses in Chemicals America and R4.7 billion in unrealized gains from asset translations and financial instrument valuations.
For FY24, Sasol expects core headline earnings per share (CHEPS) to range between R35.03 and R43.62, down 9% to 27% <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">from the previous year&#8217;s R47.71</a>.
Price Action: SSL shares are down 2.38% at $6.97 at the last check Monday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/40312018" target="_blank" rel="noreferrer noopener">TotalEnergies Accelerates Decarbonization with Biofuel Breakthrough: Details</a></li>
</ul>

Equities

Mid Cap

Guidance

Chemicals Division Weighs Heavily on Sasol's FY24 Financial Results: Details

U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Monday.
Shares of IQVIA Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) rose sharply during Monday's session after the company released better-than-expected second-quarter financial results and <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39885871/iqvia-is-a-solid-investment-with-strong-competitive-positioning-analyst-says-after-">raised its 2024 guidance</a>.
IQVIA reported a second adjusted EPS of $2.64, up from $2.43, beating the consensus of $2.57. Provider of advanced analytics reported sales of $3.81 billion, beating the consensus of $3.79 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
IQVIA Holdings shares jumped 7.4% to $241.07 on Monday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>Tellurian Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TELL#NASDAQ">TELL</a>) shares surged 64.5% to $0.9401 after the company announced it will be acquired by Woodside Energy for approximately $900 million.</li>
<li>Serve Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) shares gained 46.6% to $11.08 after Nvidia last week disclosed a stake in the company.</li>
<li>Cassava Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>) gained 27.2% to $12.82 after the company announced its first Phase 3 trial is expected to conclude by December and its second Phase 3 trial is expected to conclude by June 2025.</li>
<li>Embecta Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EMBC#NASDAQ">EMBC</a>) climbed 16.4% to $15.34. Embecta is scheduled to host a conference call to discuss its fiscal third quarter 2024 financial results on Friday, Aug. 9.</li>
<li>Terex Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEX#NYSE">TEX</a>) gained 11.2% to $62.76 after the company inked a deal to acquire Environmental Solutions Group (ESG) from Dover Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOV#NYSE">DOV</a>) in a $2.0 billion all-cash transaction.</li>
<li>Aveanna Healthcare Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAH#NASDAQ">AVAH</a>) gained 10.5% to $3.80. Aveanna Healthcare will release its second quarter results before the market open on Thursday, Aug. 8.</li>
<li>Karooooo Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KARO#NASDAQ">KARO</a>) climbed 10.4% to $37.78.</li>
<li>Eliem Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELYM#NASDAQ">ELYM</a>) gained 9.7% to $8.01.</li>
<li>Clearwater Paper Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) rose 9.6% to $53.65 after the company announced a deal to sell its tissue business for $1.06 billion.</li>
<li>SentinelOne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) shares climbed 9.5% to $23.80 after a failed software update from CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) caused global outages.</li>
<li>Summit Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) gained 9% to $9.57.</li>
<li>Sasol Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>) rose 8.8% to $7.96.</li>
<li>Rentokil Initial plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTO#NYSE">RTO</a>) surged 8% to $31.91 following a report suggesting former BT CEO Philip Jansen is in talks to acquire the company.</li>
<li>Noah Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOAH#NYSE">NOAH</a>) rose 7.7% to $7.78.</li>
<li>TAL Education Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAL#NYSE">TAL</a>) gained 7.4% to $10.84. TAL Education will release its unaudited financial results for the first quarter, before the opening bell on Thursday, Aug. 1.</li>
<li>Reddit, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) gained 5.6% to $68.32 after the company announced deals with major sports leagues to get content to its site and draw advertisers.</li>
<li>MINISO Group Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNSO#NYSE">MNSO</a>) gained 5.6% to $18.10.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39881674/top-4-tech-stocks-that-may-explode-in-july">Top 4 Tech Stocks That May Explode In July</a></li>
</ul>

Intraday Update

AVAH

CRWD

ELYM

EMBC

KARO

MNSO

NOAH

RDDT

SAVA

SERV

SMMT

TELL

IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday

On CNBC's &#8220;<a href="https://www.benzinga.com/topic/mad-money-lightning-round">Mad Money Lightning Round</a>,&#8221; Jim Cramer said Dover Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOV#NYSE">DOV</a>) is a &#8220;terrific industrial company that really is making a great move in the data center.&#8221; 
&#8220;Dover is going to be a <a href="https://www.benzinga.com/quote/DOV/earnings">big name for me</a>,&#8221; he added.
Dover is expected to release second-quarter 2024 earnings on Thursday, July 25. Analysts expect the company to report quarterly earnings at $2.21 per share, up from $2.05 per share in the year-ago period. The company is projected to post revenue of $2.14 billion, compared to $2.2 billion a year earlier.
When asked about Sasol Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>), he said, &#8220;No, if you're going to do that you want to buy Dow, no longer Dow Chemicals, Dow Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>).&#8221;
On June 20, Sasol announced that the court ruled in favor of the company and TotalEnergies Marketing. Also, it was awarded R3.89 billion in damages and <a href="https://www.benzinga.com/markets/equities/24/06/39412202/sasol-soars-on-pipeline-payday-court-awards-344m-in-tariff-dispute">approximately R2.3 billion in interest</a>.
&#8220;Don't panic, understand that they're coming down, just as a sector rotation,&#8221; Cramer said when asked about CAVA Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>).
On June 5, after a SEC filing disclosed that the company&#8217;s largest shareholder, Artal International, filed a notice regarding an order to sell 3 million shares following a conversion of Series E preferred stock into common stock.
When asked about New Fortress Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>), he said, &#8220;I think the problem here is, frankly, that President Biden put a pause. And I know that there's a judge that said no to that, but I think it put the whole multi-year plan under question, and that's why it's going down.&#8221;
On July 1, New Fortress Energy announced that it has entered into a definitive agreement to sell its liquefaction and storage facility in Miami, Florida to a U.S. middle-market infrastructure fund.
Price Action:
<ul>
<li>Dover shares gained 2% to settle at $178.56 on Wednesday.</li>
<li>Sasol shares fell 2.8% to close at $7.62 during Wednesday's session.</li>
<li>Cava shares fell 5.5% to close at $85.30.</li>
<li>New Fortress Energy shares gained 1.3% to close at $19.55 on Wednesday.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39708358/wall-streets-most-accurate-analysts-weigh-in-on-3-consumer-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>

Restaurants

CAVA

Jim Cramer Says 'Don't Panic' About Cava, Calls This Industrial Company 'Terrific'

These mid-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>Bilibili Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BILI#NASDAQ">BILI</a>) shares rose 23.32% following last week&#8217;s release of &#8216;San Guo: Mou Ding Tian Xia.&#8217; Also, JP Morgan analyst Daniel Chen upgraded Bilibili from Neutral to Overweight and <a href="https://www.benzinga.com//node/39418621" target="_blank" rel="noreferrer noopener">announced a $21 price forecast</a>.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) shares jumped 22.36% on continued strength after the announcement of insurance coverage of ANKTIVA across multiple states <a href="https://www.benzinga.com//node/39417764" target="_blank" rel="noreferrer noopener">with the first commercial doses administered</a>.</li>
<li>Sasol Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>) shares escalated 20.89% after the company announced that the court ruled in favor of the company and TotalEnergies SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTE#NYSE">TTE</a>) Marketing. Also, it was awarded R3.89B in damages <a href="https://www.benzinga.com//node/39412202" target="_blank" rel="noreferrer noopener">and approximately R2.3B in interest</a>.</li>
<li>Ollie&#8217;s Bargain Outlet Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>) stock gained 15.25% in the last week after JP Morgan <a href="https://www.benzinga.com/quote/OLLI/analyst-ratings">upgraded the stock</a> from Neutral to Overweight.</li>
<li>Intra-Cellular Therapies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITCI#NASDAQ">ITCI</a>) stock was up 13.18% after the company announced topline results from its second Phase 3 trial evaluating Lumateperone as adjunctive therapy for patients with major depressive disorder, <a href="https://www.benzinga.com//node/39382029" target="_blank" rel="noreferrer noopener">meeting primary and key secondary endpoints</a>.</li>
<li>Amkor Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) shares advanced 12.06% on overall strength in chip stocks. Also, B. Riley Securities analyst <a href="https://www.benzinga.com/quote/AMKR/analyst-ratings">raised the price forecast</a> on the stock from $45 to $50.</li>
<li>IRhythm Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>) shares grew 11.53% after the company announced that it reached a corporate milestone after it launched the initial phases of its previously disclosed <a href="https://www.benzinga.com//node/39411935" target="_blank" rel="noreferrer noopener">manufacturing automation plans</a>.</li>
<li>Rocket Lab USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) shares upped 11.32% after signing a 10-launch deal with <a href="https://www.benzinga.com//node/39429411" target="_blank" rel="noreferrer noopener">Japanese firm Synspective in Tokyo</a>.</li>
<li>Bread Financial Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFH#NYSE">BFH</a>) stock rose 10.81% after Evercore ISI Group upgraded the stock from Underperform to In-Line and raised its price target from $42 to $45. Also, RBC Capital maintained a Sector Perform rating on the stock and raised its <a href="https://www.benzinga.com/quote/BFH/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from $38 to $45</a>.</li>
<li>BRF S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRFS#NYSE">BRFS</a>) shares rose 10.69%.</li>
</ol>
Photo via Wikimedia Commons
Also Read: <a href="https://www.benzinga.com/news/24/06/39447506/gamestop-and-first-solar-were-among-the-10-biggest-large-cap-losers-last-week-june-16-june-22-are-th">GameStop And First Solar Were Among The 10 Biggest Large Cap Losers Last Week (June 16-June 22): Are These In Your Portfolio?</a>

China's Bilibili And Ollie's Bargain Outlet Were Among 10 Mid Cap Stocks With Biggest Gains In The Last Week (June 16-June 22, 2024): Are They In Your Portfolio?

WIIM

Sasol shares are trading higher after the company announced that the court ruled in favor of the company and TotalEnergies Marketing. Also, it was awarded R3.89B in damages and approximately R2.3B in interest.

Sasol Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>) shares are trading higher after the company was awarded compensation in a <a href="https://www.benzinga.com/pressreleases/24/06/n39407147/high-court-awards-damages-to-sasol-against-transnet" target="_blank" rel="noreferrer noopener">High Court ruling against Transnet</a>.
On June 18, the High Court ruled in favor of Sasol Oil and TotalEnergies, awarding Sasol Oil damages of 3.89 billion rand (US$217 million) plus about 2.3 billion rand in interest, for a total of about $344 million.
Transnet SOC Ltd., through its business unit Transnet Pipelines, transports crude oil for Sasol Oil and TotalEnergies SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTE#NYSE">TTE</a>) Marketing Ltd from Durban to the Natref crude oil refinery in Sasolburg.
Sasol Oil holds 63.64% of the shares in Natref, while TotalEnergies holds 36.36%.
Notably, in 2017, Sasol Oil, after TotalEnergies, filed a lawsuit against Transnet for damages caused by its failure to comply with its obligation to set pipeline tariffs for transporting crude oil under a 1991 agreement.
This breach led to Transnet&#8217;s overcharging Sasol Oil for crude oil transportation over an extended period.
The litigation between the parties has spanned several years. The remaining issues in the litigation went to trial in the High Court of South Africa from April 15 to May 3, 2024.
Transnet reportedly disclosed its intention to appeal a court decision that awarded Sasol and TotalEnergies around 6.2 billion rand ($344 million) in damages and interest to resolve a tariff dispute, reported Reuters.
Transnet said in a statement, &#8220;The judgment thus has enormous implications not only for the public purse but also for Transnet&#8217;s ability to discharge its obligations,&#8221;
Price Action: SSL shares are up 3.45% at $7.50 premarket at the last check Thursday.
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Large Cap

Legal

Sasol Soars On Pipeline Payday: Court Awards $344M in Tariff Dispute

<ul>
<li>In 2017, Sasol Oil followed TotalEnergies in instituting legal action against Transnet for damages arising from Transnet&#39;s breach of its obligation to set pipeline tariffs for conveyance of crude oil in terms of an agreement that had been entered into between the parties in 1991. The result of the breach was that Transnet overcharged Sasol Oil for the conveyance of crude oil over a number of years.</li>
<li>The litigation between the parties has been ongoing for years and a number of issues in the matter have been determined by the High Court, Supreme Court of Appeal and Constitutional Court respectively.</li>
</ul>

Commodities

General

The Court Ruled In Favor Of Sasol Oil And Totalenergies, Awarding Sasol Oil R3.89B In Damages Plus Approximately R2.3B In Interest

In a market dealing with external shocks, value investing, or the strategy of putting money in underappreciated stocks, is fast gaining popularity. Although these stocks are apparently cheap compared to their peers, investment is made with the hope that the stock price will appreciate reasonably to match the intrinsic value of the business.
Several stocks that have surged significantly in the recent past have shown the overwhelming success of this pure-play investment strategy. Here, we discuss three such stocks &mdash; Eldorado Gold (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ego#NYSE">EGO</a>), Sasol (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ssl#NYSE">SSL</a>) and DaVita (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dva#NYSE">DVA</a>).
<h3>More on Value Investing</h3>
While searching for a suitable investment option, value investors with varied risk appetite are unlikely to consider price/earnings to growth ratio among a number of other popular metrics like price/earnings (P/E), price/sales (P/S) or price/book value (P/B).
This is because they often find this ratio complicated, considering the limitations in calculating the future earnings growth potential of a stock. Yardsticks such as dividend yield, P/E and P/B are most commonly used to single out stocks trading at a discount.
However, these ratios, while not taking into account the future growth potential of a stock, may end up convincing us to invest in stocks that are at a discount just because of their poor show. This may often lead to &quot;value traps&quot; &mdash; a situation when these value picks start to underperform over the long run as temporary problems, which, once pulled down the share price, turn out to be persistent.
In such a case, even if you buy a stock at less than its fair value, you might still end up paying more. And here comes the importance of this not-so-popular but crucial value investing metric, the PEG ratio.
The PEG ratio is defined as (Price/ Earnings)/Earnings Growth Rate
A low PEG ratio is always better for value investors.
While P/E alone fails to identify a true value stock, PEG helps to find the intrinsic value of a stock.
There are some drawbacks to using the PEG ratio, though. It doesn&#39;t consider the common situation of changing growth rates, such as the forecast of the first three years at a very high growth rate, followed by a sustainable but lower growth rate in the long term.
Hence, PEG-based investing can turn out to be even more rewarding if some other relevant parameters are also taken into consideration.
Here are some of the screening criteria for a winning strategy:
PEG Ratio less than X Industry Median
P/E Ratio (using F1) less than X Industry Median (for more accurate valuation purpose)
Zacks Rank of 1 (Strong Buy) or 2 (Buy) (Whether good market conditions or bad, stocks with a Zacks Rank #1&nbsp;or 2 have a proven history of success.)
Market Capitalization greater than $1 Billion (This helps us to focus on companies that have strong liquidity.)
Average 20-Day Volume greater than 50,000 (A substantial trading volume ensures that the stock is easily tradable.)
Percentage Change F1 Earnings Estimate Revisions (4 Weeks) greater than 5% (Upward estimate revisions add to the optimism, suggesting further bullishness.)
Value Score of less than or equal to B: Our research shows that stocks with a Style Score of A or B when combined with a Zacks Rank #1, 2 or 3 (Hold) offer the best upside potential.&nbsp;
Here are three stocks that qualified the screening:
Eldorado Gold: The company, together with its subsidiaries, engages in the mining, exploration, development and sale of mineral products primarily in Turkey, Canada, Greece and Romania. By the end of 2024, the company expects to have completed theIntegrated Extractive Waste Management Facility (IEWMF) coffer dam and significantly advanced the IEWMF earthworks, water management facilities, process plant and filter plant.
Eldorado Gold has a long-term expected growth rate of 50.8%. EGO currently carries a Zacks Rank #2 and has a Value Score of A.
Sasol: The company operates as an integrated chemical and energy company in South Africa. Sasol uses selected technologies to safely and sustainably source, produce and market chemical and energy products competitively to create superior value for its customers, shareholders and other stakeholders.
Sasol currently holds a Zacks Rank #1 and has a Value Score of A. SSL also has an impressive five-year expected growth rate of 10.4%.
DaVita: Denver, CO-headquartered DaVita is a leading provider of dialysis services in the United States to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services, primarily in dialysis centers and in contracted hospitals across the United States. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services.
Apart from a discounted PEG and P/E, DaVita currently has a Zacks Rank #2 and a Value Score of A. DVA has a long-term historical growth rate of 15.5%.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. 
<a href="https://www.zacks.com/stock/news/2287692/3-peg-based-value-picks-to-boost-your-portfolio-returns?cid=CS-BENZ-FT-analyst_blog|rw-2287692">To read this article on Zacks.com click here.</a>

Analyst Ratings

3 PEG-Based Value Picks to Boost Your Portfolio Returns

Investors might want to bet on Sasol (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ssl#NYSE">SSL</a>), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
The sole determinant of the Zacks rating is a company&#39;s changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.
Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements.
As such, the Zacks rating upgrade for Sasol is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
Most Powerful Force Impacting Stock Prices
The change in a company&#39;s future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company&#39;s shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.
Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Sasol imply an improvement in the company&#39;s underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.
Harnessing the Power of Earnings Estimate Revisions
As empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988.
Earnings Estimate Revisions for Sasol
This energy company is expected to earn $2.55 per share for the fiscal year ending June 2024, which represents a year-over-year change of -10.5%.
Analysts have been steadily raising their estimates for Sasol. Over the past three months, the Zacks Consensus Estimate for the company has increased 6.7%.
Bottom Line
Unlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of &#39;buy&#39; and &#39;sell&#39; ratings for its entire universe of more than 4000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a &#39;Strong Buy&#39; rating and the next 15% get a &#39;Buy&#39; rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
The upgrade of Sasol to a Zacks Rank #1 positions it in the top 5% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
<a href="https://www.zacks.com/stock/news/2286836/sasol-ssl-upgraded-to-strong-buy-what-does-it-mean-for-the-stock?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2286836">To read this article on Zacks.com click here.</a>

Upgrades

Sasol Upgraded to Strong Buy: What Does It Mean for the Stock?

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Harte Hanks (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hhs#NASDAQ">HHS</a>): This data-driven, omnichannel marketing company which offers customer data landscape as well as the executional know-how in database build and management, data analytics, data-driven creativity, digital media, direct mail, customer contact, client fulfilment and marketing and product logistics, has seen the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.
<div class="chart_embed">
<h3>Harte Hanks, Inc. Price and Consensus</h3>
<img alt="Harte Hanks, Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/f1/1718099245.png" style="height:265px; width:570px" title="" />
Harte Hanks, Inc. price-consensus-chart | Harte Hanks, Inc. Quote
</div>
American Axle &amp; Manufacturing Holdings (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axl#NYSE">AXL</a>): This company which is a leading supplier of driveline and drivetrain systems, modules and components for the light vehicle market, has seen the Zacks Consensus Estimate for its current year earnings increasing 25% over the last 60 days.
<div class="chart_embed">
<h3>American Axle &amp; Manufacturing Holdings, Inc. Price and Consensus</h3>
<img alt="American Axle &amp; Manufacturing Holdings, Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/68/1718099246.png" style="height:265px; width:574px" title="" />
American Axle &amp; Manufacturing Holdings, Inc. price-consensus-chart | American Axle &amp; Manufacturing Holdings, Inc. Quote
</div>
Costamare (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cmre#NYSE">CMRE</a>): This company which operates as a containership owner chartering its vessels to liner companies, has seen the Zacks Consensus Estimate for its current year earnings increasing 12% over the last 60 day.
<div class="chart_embed">
<h3>Costamare Inc. Price and Consensus</h3>
<img alt="Costamare Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/14/1718099248.png" style="height:265px; width:577px" title="" />
Costamare Inc. price-consensus-chart | Costamare Inc. Quote
</div>
Sasol (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ssl#NYSE">SSL</a>): This company which is engaged in the mining and processing of coal, has seen the Zacks Consensus Estimate for its current year earnings increasing 6.7% over the last 60 days.
<div class="chart_embed">
<h3>Sasol Ltd. Price and Consensus</h3>
<img alt="Sasol Ltd. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/b0/1718099250.png" style="height:265px; width:570px" title="" />
Sasol Ltd. price-consensus-chart | Sasol Ltd. Quote
</div>
Aptiv (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aptv#NYSE">APTV</a>): This global technology and mobility company which is a designer and manufacturer of vehicle components as well as provider of electrical, electronic and safety technology solutions to the global automotive market, has seen the Zacks Consensus Estimate for its current year earnings increasing 6% over the last 60 days.
<div class="chart_embed">
<h3>Aptiv PLC Price and Consensus</h3>
<img alt="Aptiv PLC Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/f5/1718099252.png" style="height:265px; width:577px" title="" />
Aptiv PLC price-consensus-chart | Aptiv PLC Quote
</div>
<a href="https://www.zacks.com/commentary/2285105/new-strong-buy-stocks-for-june-11th?cid=CS-BENZ-FT-zacks_1_rank_additions-2285105">To read this article on Zacks.com click here.</a>

Financial Advisors

Small Cap

Personal Finance

APTV

CMRE

New Strong Buy Stocks for June 11th

U.S. stock futures were lower this morning, with the Dow futures falling around 300 points on Thursday.
Shares of UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) fell sharply in today's pre-market trading after the company reported <a href="https://www.benzinga.com/news/earnings/24/05/39074378/uipath-stock-plummets-after-q1-results-heres-why">first-quarter earnings and announced a CEO transition.</a>
UiPath reported quarterly earnings of 13 cents per share, which beat the analyst consensus estimate of 12 cents by 8.33%. Quarterly sales came in at $335 million, which beat the analyst consensus estimate of $333.04 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
The company also announced Rob Enslin will resign as CEO and as a member of the UiPath board of directors, effective June 1, 2024.
UiPath shares dipped 29.5% to $12.91 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Salesforce, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) shares declined 15.6% to $228.55 in pre-market trading. Salesforce reported upbeat earnings for the first quarter, while sales missed estimates. The company issued weak guidance for the second quarter.</li>
<li>Nutanix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) tumbled 10.2% to $65.80 in pre-market trading after reporting quarterly earnings.</li>
<li>American Eagle Outfitters, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEO#NYSE">AEO</a>) shares fell 8.5% to $22.01 in pre-market trading following first-quarter results.</li>
<li>Fitell Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) shares declined 7.1% to $15.80 in pre-market trading.</li>
<li>nCino Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>) shares fell 7% to $28.05 in pre-market trading following soft second-quarter guidance.</li>
<li>Sasol Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>) fell 5.8% to $6.55 in pre-market trading.</li>
<li>ServiceNow, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) shares fell 4.4% to $699.15 in pre-market trading.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/39077847/investor-optimism-decreases-dow-tumbles-over-400-points">Investor Optimism Decreases; Dow Tumbles Over 400 Points</a>
Don't forget to check out our p<a href="https://www.benzinga.com/premarket/">remarket coverage here</a>

FTEL

NCNO

NTNX

PATH

UiPath, Salesforce, Nutanix And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining around 0.5% on Tuesday.
Shares of Hello Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOMO#NASDAQ">MOMO</a>) fell sharply in today's pre-market trading following <a href="https://www.benzinga.com/quote/MOMO/earnings">first-quarter results</a>.
Hello Group posted adjusted EPADS of 4 cents, compared to market expectations of 29 cents. The company's sales came in at $354.61 million versus estimates of $347.95 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Hello Group shares fell 4.9% to $5.25 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>MultiPlan Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPLN#NYSE">MPLN</a>) shares dipped 9.8% to $0.6198 in pre-market trading after jumping 22% on Friday.</li>
<li>Larimar Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRMR#NASDAQ">LRMR</a>) shares fell 6.2% to $6.64 in pre-market trading. Larimar Therapeutics, last week, announced that the FDA removed the partial clinical hold previously placed on the nomlabofusp clinical program.</li>
<li>Bowlero Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOWL#NYSE">BOWL</a>) shares declined 6.1% to $11.40 in pre-market trading. Bowlero recently announced the acquisition of Thunderbowl Lanes in Michigan.</li>
<li>DraftKings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) shares fell 5.2% to $38.67 in pre-market trading. DraftKings, last week, completed the acquisition of Jackpocket.</li>
<li>Axsome Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXSM#NASDAQ">AXSM</a>) shares fell 4.7% to $71.62 in pre-market trading.</li>
<li>Flutter Entertainment plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLUT#NYSE">FLUT</a>) shares fell 3.3% to $197.39 in pre-market trading.</li>
<li>Sea Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SE#NYSE">SE</a>) shares declined 3.2% to $69.70 in pre-market trading.</li>
<li>Sasol Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>) shares fell 3.1% to $7.00 in pre-market trading.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/39032628/investor-optimism-improves-nasdaq-settles-at-record-high">Investor Optimism Improves, Nasdaq Settles At Record High</a>
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>

AXSM

BOWL

DKNG

FLUT

Larimar Therapeutics, Inc. - Common Stock

LRMR

MOMO

MPLN

Hello Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Shareholders are advised in terms of paragraph 3.59 of the JSE Listings Requirements that Mr&nbsp;Hanr&eacute;&nbsp;Rossouw has informed the Company that he will step down as Chief Financial Officer and executive director of Sasol Limited on&nbsp;31 October 2024.
Mr&nbsp;Steve Westwell, the Chairman of Sasol, said: &quot;Hanr&eacute; joined Sasol on 4&nbsp;April 2022 and has made a solid contribution towards achieving Future Sasol.&quot; Ms&nbsp;Trix Kennealy, Chairman of the Audit Committee, added: &quot;We thank Hanr&eacute; for his leadership during a challenging period and wish him well in his future endeavours.&quot;
Hanr&eacute; will remain with Sasol for the financial year-end closing and the publication of their suite of annual reports for the year ending&nbsp;30 June 2024, allowing for a structured&nbsp;handover period. Sasol has commenced the succession process and an announcement will be made in due course.

Management

Hanré Rossouw to Step Down as Sasol Ltd CFO and Director on October 31

Shares of Nucor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) fell sharply during Tuesday's session after the company reported worse-than-expected <a href="https://www.benzinga.com/news/earnings/24/04/38365860/nucor-shares-fall-after-worse-than-expected-q1-results">quarterly financial results</a>.
Nucor reported quarterly earnings of $3.46 per share which missed the analyst consensus estimate of $3.65. Quarterly sales came in at $8.14 billion, missing the analyst consensus estimate of $8.26 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Nucor shares tumbled 6.5% to $179.20 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Cyngn Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) shares jumped 100% to $0.2419 after the company announced that it has been chosen to supply its DriveMod Tuggers for industrial automation to John Deere&#8217;s operation in Dubuque, Iowa.</li>
<li>Pineapple Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NASDAQ">PEGY</a>) shares climbed 50.4% to $0.0689 after falling 10% on Monday.</li>
<li>Oportun Financial Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRT#NASDAQ">OPRT</a>) gained 46% to $3.29 after the company announced preliminary first-quarter total revenue above estimates.</li>
<li>Palisade Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALI#NASDAQ">PALI</a>) shares climbed 44.3% to $7.12 after the company entered a collaboration with Strand Life Sciences.</li>
<li>KULR Technology Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KULR#NASDAQ">KULR</a>) gained 27% to $0.5683 after the company announced it delivered on an immediate basis, a power cell battery deployment order for AI-enabled drone and advanced air mobility missions in Ukraine.</li>
<li>Smart for Life, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMFL#NASDAQ">SMFL</a>) climbed 20% to $5.22.</li>
<li>HWH International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWH#NASDAQ">HWH</a>) rose 19.5% to $1.5307 after declining 3% on Monday.</li>
<li>SolarMax Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMXT#NASDAQ">SMXT</a>) gained 18.7% to $9.49.</li>
<li>Hibbett, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) rose 18.4% to $85.85 after the company agreed to be acquired by JD Sports Fashion for $87.50 per share in cash, in a $1.1 billion transaction.</li>
<li>SES AI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) gained 17.4% to $1.3499.</li>
<li>SolarMax Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMXT#NASDAQ">SMXT</a>) rose 15.5% to $9.24.</li>
<li>FuelCell Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCEL#NASDAQ">FCEL</a>) gained 15.5% to $0.9295.</li>
<li>Carmell Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTCX#NASDAQ">CTCX</a>) climbed 15.2% to $2.20.</li>
<li>Azitra, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#NYSE">AZTR</a>) shares gained 15% to $0.2244 after the company announced new preclinical data will be presented at the American Society of Gene and Cell Therapy meeting.</li>
<li>Virgin Galactic Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NASDAQ">SPCE</a>) jumped 14.4% to $0.8603.</li>
<li>9F Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFU#NASDAQ">JFU</a>) rose 14.3% to $3.29.</li>
<li>Canaan Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) gained 14% to $1.05. The company executives announced intentions to purchase at least $2 million of the company's common stock.</li>
<li>Cartesian Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAC#NASDAQ">RNAC</a>) jumped 12.7% to $20.59 after Leerink Partners initiated coverage on the stock with an Outperform rating and announced a $39 price target.</li>
<li>Spotify Technology S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) gained 12.3% to $305.73 following first-quarter financial results.</li>
<li>Heron Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRTX#NASDAQ">HRTX</a>) climbed 11.6% to $2.89 after Capital One initiated coverage on the stock with an Overweight rating and $6 price target.</li>
<li>Mesoblast Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) gained 9.4% to $6.05.</li>
<li>Ryder System, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/R#NYSE">R</a>) rose 9% to $118.82 following better-than-expected quarterly earnings.</li>
<li>Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) jumped 8.8% to $10.15.</li>
<li>HealthStream, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSTM#NASDAQ">HSTM</a>) surged 7.4% to $25.91 following upbeat quarterly results.</li>
<li>Cidara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) shares rose 7% to $0.55 following upbeat quarterly results.</li>
<li>Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) gained 6.2% to $62.20.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Abeona Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABEO#NASDAQ">ABEO</a>) fell 48.4% to $3.7950 after the company announced the FDA issued a Complete Response Letter in response to the company&#8217;s Biologics License Application for pz-cel for the treatment of patients with recessive dystrophic epidermolysis bullosa.</li>
<li>Greenwave Technology Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWAV#NASDAQ">GWAV</a>) shares fell 44.6% to $0.0699. Greenwave Technology Solutions disclosed that it further strengthened its balance sheet by approximately $12 million.</li>
<li>Lichen China Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LICN#NASDAQ">LICN</a>) fell 44.4% to $0.5450.</li>
<li>Tungray Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRSG#NASDAQ">TRSG</a>) shares declined 34.2% to $4.87 after gaining 24% on Monday.</li>
<li>Tian Ruixiang Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIRX#NASDAQ">TIRX</a>) fell 26.3% to $0.5091.</li>
<li>Moolec Science SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLEC#NASDAQ">MLEC</a>) fell 24.3% to $1.87. On April 22, Moolec Science said it received approval for its plant-grown animal proteins.</li>
<li>YY Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YYGH#NASDAQ">YYGH</a>) fell 22.4% to $2.25 after tumbling over 27% on Monday. The company, last week, priced its IPO at $4 per share.</li>
<li>Top Wealth Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWG#NASDAQ">TWG</a>) dipped 19.7% to $2.0899.</li>
<li>Comstock Holding Companies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHCI#NASDAQ">CHCI</a>) declined 18.8% to $6.44.</li>
<li>SuperCom Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPCB#NASDAQ">SPCB</a>) dipped 18% to $0.2369. SuperCom recently reported better-than-expected quarterly results.</li>
<li>JetBlue Airways Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) declined 16.2% to $6.29 after the company reported first-quarter financial results and issued worse-than-expected Q2 and FY24 Revenue outlook.</li>
<li>MSCI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) declined 13% to $448.01 following first-quarter financial results.</li>
<li>LKQ Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKQ#NASDAQ">LKQ</a>) fell 12.6% to $42.78 after the company reported a first-quarter earnings miss and cut its FY24 outlook.</li>
<li>Simpson Manufacturing Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSD#NYSE">SSD</a>) dipped 11.7% to $163.40 following weak quarterly earnings.</li>
<li>Jaguar Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) shares fell 11.2% to $0.1598 after the company filed for a mixed shelf offering of up to $75 million.</li>
<li>Xerox Holdings Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRX#NASDAQ">XRX</a>) tumbled 11.1% to $14.60 after the company reported worse-than-expected first-quarter results and reiterated FY24 guidance.</li>
<li>T2 Biosystems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTOO#NASDAQ">TTOO</a>) declined 10.4% to $2.83 after gaining around 7% on Monday.</li>
<li>Sasol Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>) shares fell 10.1% to $7.13 after the company issued its production and sales performance metrics for the nine months ended 31 March, 2024.</li>
<li>Complete Solaria, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSLR#NASDAQ">CSLR</a>) fell 9.3% to $0.3530 after dipping around 14% on Monday.</li>
<li>Cleveland-Cliffs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) dipped 7.8% to $19.22 after the company&#8217;s reported worse-than-expected first-quarter financial results.</li>
<li>Phio Pharmaceuticals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) fell 7.1% to $0.77. Phio Pharmaceuticals shares jumped around 33% on Monday after the company announced that its intratumoral injection of murine PH-762 inhibited tumor growth in murine tumor models and may generate memory-specific T cells.</li>
<li>Calix, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>) shares fell 4.1% to $28.34 after the company reported mixed first-quarter financial results and issued second-quarter guidance below estimates.</li>
</ul>
Read More: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38379861/bitcoin-surpasses-66-000-akash-network-core-among-top-gainers">Bitcoin Surpasses $66,000; Akash Network, Core Among Top Gainers</a>

ABEO

AZTR

CALX

CDTX

CHCI

CSLR

CTCX

FCEL

GWAV

HIBB

HRTX

HSTM

JAGX

JBLU

KULR

LICN

MESO

MLEC

MSCI

OPRT

PALI

PEGY

PHIO

RNAC

ROKU

SMFL

SMXT

SPCB

SPCE

SPOT

TIRX

TRSG

TTOO

YYGH

Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Sasol shares are trading lower. The company reported production and sales metrics for the none months ended March 31, 2024.

U.S. stock futures were slightly higher this morning, with the Dow futures gaining over 20 points on Tuesday.
Shares of Calix, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>) fell sharply in today's pre-market trading after the company reported mixed first-quarter financial results and issued second-quarter <a href="https://www.benzinga.com/quote/CALX">guidance below estimates</a>.
Calix posted adjusted earnings of 21 cents per share, beating market estimates of 20 cents per share. The company's quarterly sales came in at $226.310 million, missing expectations of $228.139 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Calix shares dipped 16.8% to $24.60 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Abeona Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABEO#NASDAQ">ABEO</a>) fell 48.1% to $3.82 in pre-market trading after the company announced the FDA issued a Complete Response Letter in response to the company&#8217;s Biologics License Application for pz-cel for the treatment of patients with recessive dystrophic epidermolysis bullosa.</li>
<li>Sasol Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>) shares fell 8.1% to $7.29 in pre-market trading after the company issued published its production and sales performance metrics for the nine months ended 31 March, 2024.</li>
<li>Cadence Design Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>) fell 5.7% to $268.91 pre-market trading after the company issued second-quarter guidance below estimates.</li>
<li>Harmony Gold Mining Company Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMY#NYSE">HMY</a>) shares slipped 4.5% to $8.32 in pre-market trading after falling 6% on Monday.</li>
<li>Mobile-health Network Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDR#NASDAQ">MNDR</a>) shares fell 4.1% to $22.87 in pre-market trading after dipping over 12% on Monday. The company issued H1 2024 financial guidance.</li>
<li>Sibanye Stillwater Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBSW#NYSE">SBSW</a>) shares fell 4% to $4.78 in pre-market trading.</li>
<li>Lufax Holding Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LU#NYSE">LU</a>) shares declined 3.9% to $4.22 in pre-market trading after the company reported first-quarter results and said David Siu Kam Choy tendered his resignation as CFO due to personal reasons.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/04/38370585/investor-optimism-improves-but-fear-greed-index-remains-in-fear-zone">Investor Optimism Improves, But Fear &amp; Greed Index Remains In &#8216;Fear&#8217; Zone</a>
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>

CDNS

MNDR

SBSW

Calix Reports Mixed Results, Joins Cadence Design Systems And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Sasol's Nine Months Ended March 31, 2024 Mining Productivity +4% YoY, Gas Production +8% YoY, SO Production Volumes +3% YoY, And Total Chemicals Sales Volumes + 4% YoY

Sasol announces CFO transition

Are AI Stocks A Better Investment Then Value Stocks?

Executive reshuffles: The ODP, GrafTech International and ICON Companies in focus

Sasol FY 2024 Earnings Preview

Here's the major earnings before the open tomorrow

Sasol Non-GAAP EPS of R$18.19, external turnover of R$272.75B

Analyst Sashank Lanka of Bank of America Securities maintained a Buy rating on Sasol (SASOF – Research Report), boosting the price target to $10.89...

Sasol's Strong Financial Performance and Strategic Dividend Policy Garner Buy Rating

Sasol to review assets including Lake Charles after swinging to full-year loss

Sasol Limited (SSL) Q3 2024 Earnings Call Transcript

Saudi Aramco, Sasol among competitors for Shell South Africa assets - Bloomberg

AAPL

AMZN

ARLP

BEPC

BXSL

CTSO

EXPE

FRST

FUTU

GLPEF

GLPEY

GOOG

HROW

HTHT

ICLR

MSFT

NNDM

NNOX

NVDA

NXST

RBBN

REPYF

REPYY

SACH

SASOF

SBLK

SHEL

TSLA

VALE

WKHS

XPEV

Press Releases

SUCCESSFUL CONCLUSION OF THE DECISION OF THE MINISTER OF FORESTRY, FISHERIES AND THE ENVIRONMENT ON SASOL'S APPEAL RELATED TO ITS CLAUSE 12A APPLICATION

Comments

Sasol

뉴스

에 대한 최신 뉴스 Sasol (NYSE:SSL) 주식

월요일, 6월 24, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌